AMN · Amn Healthcare Services Inc - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $2.73B | $2.98B | $3.79B | $5.24B | $3.98B | $2.39B |
| Cost of Revenue | $1.96B | $2.06B | $2.54B | $3.53B | $2.67B | $1.60B |
| Gross Profit | $774.06M | $919.38M | $1.25B | $1.72B | $1.31B | $791.78M |
| R&D | - | - | - | - | - | - |
| SG&A | $593.02M | $632.49M | $756.24M | $936.58M | $730.45M | $549.75M |
| Total Operating Expenses | $829.53M | $1.02B | $911.15M | $1.07B | $831.60M | $642.51M |
| D&A | $156.60M | $173.78M | $160.93M | $137.11M | $103.70M | $94.19M |
| Operating Income | ($55.47M) | ($102.67M) | $338.43M | $647.10M | $478.00M | $149.26M |
| Interest Expense | $45.59M | $69.90M | $54.14M | $40.40M | $34.08M | $57.74M |
| Income Tax | ($5.36M) | ($25.59M) | $73.61M | $162.65M | $116.53M | $20.86M |
| Net Income | ($95.70M) | ($146.98M) | $210.68M | $444.05M | $327.39M | $70.67M |
| EPS - Basic | ($2.48) | ($3.85) | $5.38 | $9.96 | $6.87 | $1.49 |
| EPS - Diluted | ($2.48) | ($3.85) | $5.36 | $9.90 | $6.81 | $1.48 |
Balance Sheet
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $33.97M | $10.65M | $32.94M | $64.52M | $180.93M | $29.21M |
| Accounts Receivable | $382.56M | $437.82M | $623.49M | $675.65M | $789.13M | $376.10M |
| Inventory | - | - | - | - | - | - |
| Accounts Payable | $161.97M | $184.31M | $343.85M | $476.45M | $425.26M | $167.88M |
| Current Assets | $545.38M | $594.91M | $841.68M | $1.09B | $1.35B | $533.74M |
| Total Assets | $2.09B | $2.42B | $2.92B | $2.89B | $3.13B | $2.35B |
| Current Liabilities | $577.61M | $545.78M | $656.12M | $857.93M | $969.39M | $422.96M |
| Long-term Debt | $767.05M | $1.06B | $1.30B | $843.50M | $842.32M | $857.96M |
| Total Liabilities | $1.45B | $1.71B | $2.09B | $1.84B | $1.97B | $1.53B |
| Stockholders' Equity | $642.11M | $706.62M | $831.26M | $1.04B | $1.16B | $819.68M |
| Retained Earnings | $1.21B | $1.30B | $1.45B | $1.24B | $796.95M | $469.56M |
Cash Flow
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | $269.46M | $320.42M | $372.17M | $653.73M | $305.36M | $256.83M |
| Investing Cash Flow | $4.30M | ($79.94M) | ($412.49M) | ($170.71M) | ($107.40M) | ($538.17M) |
| Financing Cash Flow | ($295.89M) | ($259.45M) | $10.73M | ($591.87M) | ($34.90M) | $211.49M |
| CapEx | $35.63M | $80.89M | $103.69M | $75.83M | $53.57M | $37.70M |
| Free Cash Flow | $233.83M | $239.53M | $268.48M | $577.90M | $251.78M | $219.12M |
Ratios
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 28.3% | 30.8% | 33.0% | 32.7% | 32.9% | 33.1% |
| Operating margin | -2.0% | -3.4% | 8.9% | 12.3% | 12.0% | 6.2% |
| EBITDA margin | 3.7% | 2.4% | 13.2% | 15.0% | 14.6% | 10.2% |
| Net margin | -3.5% | -4.9% | 5.6% | 8.5% | 8.2% | 3.0% |
| Free cash flow margin | 8.6% | 8.0% | 7.1% | 11.0% | 6.3% | 9.2% |
| FCF / Net income | -2.44 | -1.63 | 1.27 | 1.30 | 0.77 | 3.10 |
| R&D / Revenue | - | - | - | - | - | - |
| SG&A / Revenue | 21.7% | 21.2% | 20.0% | 17.9% | 18.3% | 23.0% |
| Effective tax rate | - | - | 25.9% | 26.8% | 26.3% | 22.8% |
| Return on assets | -4.6% | -6.1% | 7.2% | 15.4% | 10.5% | 3.0% |
| Return on equity | -14.9% | -20.8% | 25.3% | 42.5% | 28.2% | 8.6% |
| Return on invested capital | -3.1% | -4.6% | 11.7% | 25.1% | 17.6% | 6.9% |
| Liquidity | ||||||
| Current ratio | 0.94 | 1.09 | 1.28 | 1.27 | 1.39 | 1.26 |
| Quick ratio | 0.94 | 1.09 | 1.28 | 1.27 | 1.39 | 1.26 |
| Cash ratio | 0.06 | 0.02 | 0.05 | 0.08 | 0.19 | 0.07 |
| Leverage | ||||||
| Debt / Equity | 1.19 | 1.49 | 1.57 | 0.81 | 0.72 | 1.05 |
| Debt / Assets | 0.37 | 0.44 | 0.45 | 0.29 | 0.27 | 0.36 |
| Debt / EBITDA | 7.58 | 14.85 | 2.61 | 1.08 | 1.45 | 3.52 |
| Interest coverage | -1.2x | -1.5x | 6.3x | 16.0x | 14.0x | 2.6x |
| Equity multiplier | 3.26 | 3.42 | 3.52 | 2.77 | 2.70 | 2.87 |
| Liabilities / Assets | 0.69 | 0.71 | 0.72 | 0.64 | 0.63 | 0.65 |
| Efficiency | ||||||
| Asset turnover | 1.30 | 1.24 | 1.30 | 1.82 | 1.27 | 1.02 |
| Inventory turnover | - | - | - | - | - | - |
| Days sales outstanding | 51d | 54d | 60d | 47d | 72d | 57d |
| Days inventory outstanding | - | - | - | - | - | - |
| Days payable outstanding | 30d | 33d | 49d | 49d | 58d | 38d |
| Cash conversion cycle | - | - | - | - | - | - |
| Valuation | ||||||
| P / E | - | - | 14.0x | 10.4x | 18.0x | 46.1x |
| P / B | 0.9x | 1.3x | 3.5x | 4.4x | 5.1x | 4.0x |
| P / S | 0.2x | 0.3x | 0.8x | 0.9x | 1.5x | 1.4x |
| EV / EBITDA | 13.3x | 27.5x | 8.4x | 6.9x | 11.2x | 16.8x |
| Growth | ||||||
| Revenue growth (YoY) | -8.5% | -21.3% | -27.7% | 31.6% | 66.4% | 7.7% |
| Revenue CAGR (3y) | -19.5% | -9.2% | 16.5% | 33.1% | 27.9% | 6.4% |
| Revenue CAGR (5y) | 2.7% | 6.1% | 14.8% | 21.4% | 15.9% | 10.3% |
| Gross profit growth (YoY) | -15.8% | -26.4% | -27.2% | 31.1% | 65.4% | 6.5% |
| Operating income growth (YoY) | 46.0% | - | -47.7% | 35.4% | 220.2% | -15.6% |
| Net income growth (YoY) | 34.9% | - | -52.6% | 35.6% | 363.3% | -38.0% |
| EPS growth (YoY) | 35.6% | - | -45.9% | 45.4% | 360.1% | -38.3% |
| EPS CAGR (3y) | - | - | 53.6% | 60.4% | 32.8% | -18.0% |
| EPS CAGR (5y) | - | - | 13.0% | 29.9% | 25.9% | -2.5% |
| FCF growth (YoY) | -2.4% | -10.8% | -53.5% | 129.5% | 14.9% | 15.5% |
| FCF CAGR (5y) | 1.3% | 4.8% | 7.0% | 45.5% | 18.0% | 49.5% |
| Book value growth (YoY) | -9.1% | -15.0% | -20.3% | -10.2% | 41.8% | 11.3% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2025-12-31.
Business segments
$2.73B totalNurse And Allied Healthcare Staffing$1.65B · 60.3%
Physician And Leadership Solutions$696.36M · 25.5%
Technology And Workforce Solutions$386.75M · 14.2%
Product / service
$4.97B totalTemporary Staffing$1.64B · 33.0%
Travel Nurse Staffing$827.68M · 16.7%
Allied Staffing$582.32M · 11.7%
Locum Tenens Staffing$565.17M · 11.4%
Technology Enabled Services$375.86M · 7.6%
Language Services$295.51M · 6.0%
Labor Disruption Services$191.19M · 3.9%
International Nurse$129.09M · 2.6%
International Nurse Staffing$119.77M · 2.4%
Interim Leadership Staffing$93.92M · 1.9%
Vendor Management Systems$71.67M · 1.4%
Local Staffing$36.81M · 0.7%
Talent Planning And Acquisition$10.88M · 0.2%
International Nurse Permanent Placement$9.32M · 0.2%
Permanent Placement$9.32M · 0.2%
Other Technologies$8.68M · 0.2%
Stability scores
Altman Z′
FY 2025 · bankruptcy risk
1.88
Grey zone
Private-firm variant - uses book equity instead of market cap. > 2.90 safe · 1.23-2.90 grey · < 1.23 distress.
Piotroski F-score
FY 2025 · 9-point quality
6/9
Neutral
- ✗Net income positive
- ✓Operating cash flow positive
- ✓ROA improved YoY
- ✓Cash flow > net income
- ✓Long-term debt decreased
- ✗Current ratio improved
- ✓No share dilution
- ✗Gross margin improved
- ✓Asset turnover improved
Peer comparison
Same SIC group: Services-Help Supply Services
Comparing AMN HEALTHCARE SERVICES INC against the 5 most active filers in the same SIC group.